-+ 0.00%
-+ 0.00%
-+ 0.00%
<国家基本医疗保险、生育保险和工伤保险药品目录><商业健康保险创新药品目录>Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) issued an announcement. On November 14, 2026, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “Notice on Issuance and (2026)” [Medical Insurance (2026) No. 29]. According to the notice, the company's children's Jingxing cough tablets and Xuanqijian bone tablets will now continue to be included in the “2026 Medical Insurance Catalogue” in accordance with simple renewal rules. Other major products of the company and its wholly-owned and holding subsidiaries have not been withdrawn or added to the “2026 Medical Insurance Catalogue”.
Share
Listen to the news
Zhitong Finance App News, Fangsheng Pharmaceutical (603998.SH) issued an announcement. On November 14, 2026, the National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “Notice Concerning Issuance and (2026)” [Medical Insurance<国家基本医疗保险、生育保险和工伤保险药品目录> (2026) No. 29]. According to the notice, the company's children's Jingxing cough tablets and Xuanqijian bone tablets will now continue to be included in the “<商业健康保险创新药品目录> 2026 Medical Insurance Catalogue” in accordance with simple renewal rules. The company, wholly-owned, Other major products of the holding subsidiary have not been withdrawn or added to the “2026 Medical Insurance Catalogue”.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending